<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02606110</url>
  </required_header>
  <id_info>
    <org_study_id>ERMC 14-11</org_study_id>
    <nct_id>NCT02606110</nct_id>
  </id_info>
  <brief_title>Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eastern Regional Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eastern Regional Medical Center</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the effect of the ReBuilder in the treatment of
      individuals with breast cancer and chemotherapy induced peripheral neuropathy.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    PI decided no longer to pursue
  </why_stopped>
  <start_date>June 2014</start_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in touch and sensory by way of change in the Semmes-Weinstein Monofilament Testing</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in touch and sensory by way of changes in Functional Gait Assessment</measure>
    <time_frame>One year</time_frame>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Peripheral Neuropathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with breast cancer and chemotherapy induced peripheral neuropathy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with breast cancer referred to Physical Therapy for CIPN

          -  Physical Therapy Examination indicates use of Rebuilder for CIPN

          -  At least 18 years of age

          -  Signed informed consent for study population

          -  Willingness to complete study according to protocol

        Exclusion Criteria:

          -  Patients who do not have CIPN

          -  Patients &lt;18 years of age

          -  Inability to or unwilling to sign informed consent

          -  Unable to read and understand the English language

          -  Preexisting sensory peripheral neuropathy from other comorbid conditions such as
             diabetes or alcoholism

          -  More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days,
             for sensory peripheral neuropathy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Eastern Regional Medical Center</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19124</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2015</study_first_submitted>
  <study_first_submitted_qc>November 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 17, 2015</study_first_posted>
  <last_update_submitted>July 10, 2017</last_update_submitted>
  <last_update_submitted_qc>July 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ReBuilder</keyword>
  <keyword>breast cancer</keyword>
  <keyword>chemotherapy induced</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Nervous System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

